Young People with Pcos And T2dm: Case Studies on Public Health Care
DOI:
https://doi.org/10.36489/saudecoletiva.2024v14i92p13976-13991Keywords:
Polycystic ovary syndrome, Diabetes Mellitus type 2, Obesity, MetforminAbstract
Objective: To describe the relationship between polycystic ovary syndrome (PCOS) and type 2 diabetes mellitus (T2DM), its risk factors, as well as therapeutic options and the consequences of this disorder on women's health. Method: Four medical records of patients with PCOS in the city of Joinville were analyzed. Result: Among 469 women with PCOS and T2DM, 4 met the criteria. It was observed that metformin may be less effective for hirsutism in certain subgroups, while studies indicate that treatment with metformin and ACH improves biochemical parameters, but not obesity. This implies that the choice of treatment should be based on symptoms, observing biochemical benefits of combined treatment; targeting the main endocrine disorders: hyperinsulinemia and hyperandrogenism. Conclusion: A correlation between PCOS and obesity in the development of diabetes was observed and the need to establish a treatment to benefit both the reproductive and cardiovascular systems.
References
Azziz R. Polycystic Ovary Syndrome. Obstetrics & Gynecology. 2018 Aug;132(2):321–36. Available from: https://journals.lww.com/greenjournal/abstract/2018/08000/polycystic_ovary_syndrome.9.aspx.
Yin RK. Case study research and applications: design and methods. SAGE Publications, 2017.
STAKE, Robert E. Qualitative research: studying how things work. Guilford Press, 2010.
Fraison E, Kostova E, Moran LJ, Bilal S, Ee CC, Venetis C, et al. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database of Systematic Reviews. 2020 Aug 13;(8). Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005552.pub3/full.
Melin J, Forslund M, Alesi S, Terhi P, Romualdi D, Spritzer PM, et al. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. The Journal of Clinical Endocri- nology and Metabolism. 2023 Aug 9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10795934/.
Teede HJ, Chau TT, Joop JEL, Anuja D, Moran LJ, Terhi TP, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. European journal of endocrinology. 2023 Aug 1;189(2):G43–64. Available from: https://academic.oup.com/ejendo/article/189/2/G43/7242362.
Wu L, Liu Y, Huang X, Lin K, Liu Y, Li Z, et al. Oral contraceptives (OCs) in combination with metformin versus OCs alone on metabolism in nonobese polycystic ovary syndrome: A meta‐analysis and systematic review of randomized controlled trials. Clinical Endocrinology. 2023 Apr 7;99(1):3–16. Available from: https://onlinelibrary.wiley.com/doi/10.1111/cen.14895.
Nelson AL, Cwiak CA. Combined oral contraceptives (COCs). In: Hatcher RA (Eds.). Contraceptive Technology. 20th ed. Ardent Media, 2011. p. 249–341.
Speroff L, Fritz MA. clinical gynecologic endocrinology and infertility. 9th ed. Philadelphia: Wolters Kluwer Health, 2020.
Forslund M, Melin J, Alesi S, Piltonen T, Romualdi D, Tay CT, et al. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis. European Journal of Endocrinology [Internet]. 2023 Jul 20;189(1):S1–16. Available from: https://pubmed.ncbi.nlm.nih.gov/37440702/.
, Goldberg A, Graca S, Liu J, Rao V, Selma Feldman Witchel, Pena A, et al. Anti‐obesity pharmacological agents for poly- cystic ovary syndrome: A systematic review and meta‐anal- ysis to inform the 2023 international evidence‐based guide-line. Obesity reviews. 2024 Feb 14. Available from: https://pubmed.ncbi.nlm.nih.gov/38355887/.
Prefeitura de Joinville. REMUME - Relação municipal de medicamentos essenciais. Secretaria de Joinville. Available from: https://www.joinville.sc.gov.br/public/portaladm/pdf/jornal/3c415e8ee2afb4dcd0a97676aefac34d.pdf.
Loh HH, Yee A, Loh HS, Kanagasundram S, Francis B, Lim LL. Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis. Hormones. 2020 May 27;19(2);413–423. Available from: https://link.springer.com/article/10.1007/s42000-020-00210-0.
Hong X, Qin P, Yin J, Shi Y, Xuan Y, Chen Z, et al. Clinical manifestations of polycystic ovary syndrome and associations with the vaginal microbiome: a cross-sectional based exploratory study. Frontiers in Endocrinology. 2021 Apr 23;12. Available from: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.662725/full.
